The preliminary data of our study indicate that primary tumor SUV entropy and pleural effusion were early predictive biomarkers of survival in patients with lung adenocarcinoma treated with EGFR-targeted TKIs. The gene discussed is EGFR; the disease is lung adenocarcinoma.